Navigation Links
Kendle to Ring Opening Bell at NASDAQ Stock Market on August 22
Date:8/20/2007

Opening Bell Ceremony Marks Kendle's 10th Anniversary as Public Company

CINCINNATI, Aug. 20 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced Chairman and CEO Candace Kendle, PharmD, will ring the opening bell at the NASDAQ Stock Market on Aug. 22, 2007, the company's 10th anniversary as a publicly-traded company. The Opening Bell ceremony will take place at 9:30 a.m. Eastern Time at the NASDAQ MarketSite(R) in New York's Times Square and will be broadcast live on http://www.nasdaq.com and on the seven-story NASDAQ tower, the largest stationary video screen in the world.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )

NASDAQ Opening Bell Ceremony - Webcam Instructions

To view the NASDAQ Opening Bell ceremony, go to http://www.kendle.com or http://www.nasdaq.com/about/marketsitetowervideo.asx. Please note:

-- Viewers must have Windows Media Player to view the webcam (Windows

Media Player is downloadable at no charge from

http://www.microsoft.com/windows/windowsmedia/default.aspx).

-- It is recommended viewers download the webcam at 9:15 a.m. so there is

time to troubleshoot in the event of technical difficulties

-- Prior to 9:20 a.m., the webcam will show the Tower; at 9:20 a.m. the

router will be switched and viewers will see inside the MarketSite

studio where the ceremony will take place

-- Viewers should not be alarmed that the webcam is fuzzy. Clarity is

dependent on Internet hook up.

NASDAQ Opening Bell Ceremony - Satellite Feed Information

The opening bell is available from 9:20 a.m. to 9:35 a.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can also be found on Waterfront fiber 1623. For questions, please contact Jolene Libretto at NASDAQ at (646) 441-5220.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is among the world's leading global clinical research organizations and is the fourth-largest provider of Phase II-IV clinical development services worldwide. We deliver innovative and robust clinical development solutions - from first-in-human studies through market launch and surveillance - to help the world's biopharmaceutical companies maximize product life cycles and grow market share.

Our global clinical development business is focused on five regions - North America, Europe, Asia/Pacific, Latin America and Africa - to meet customer needs. With the expertise of our more than 3,000 associates worldwide, Kendle has conducted clinical trials and provided regulatory and pharmacovigilance services in more than 80 countries. The company was named the "Top CRO to Work With" in the Thomson CenterWatch 2007 Survey of U.S. Investigative Sites. Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company's Web site at http://www.kendle.com.


'/>"/>
SOURCE Kendle

Copyright©2007 PR Newswire.

Related biology technology :

1. Merge files financial reports by market opening
2. NASDAQ will continue to list Merge
3. NASDAQ grants Merge more time for compliance
4. NASDAQ will continue to list Merge
5. No word on NASDAQ extension for Merge
6. NASDAQ puts Merge on notice again
7. Midwest life science stocks kept sizzling in Q2
8. Madisons PunchStock acquired by Getty Images
9. Midwest life science stocks sizzle in a tepid first quarter
10. Sonic Foundry completes $11.25M stock offer
11. Sonic Foundry sets $3.75 stock price
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Hill, N.C. (PRWEB) , ... June 27, 2016 ... ... U.S. commercial operations for Amgen, will join the faculty of the University ... serve as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a ...
(Date:6/27/2016)... BOSTON , June 27, 2016   Ginkgo ... biology to industrial engineering, was today awarded as ... a selection of the world,s most innovative companies. ... at scale for the real world in the ... organism engineers work directly with customers including Fortune ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal articles ... findings are the subject of a new article on the Surviving Mesothelioma website. ... blood, lung fluid or tissue of mesothelioma patients that can help point doctors to ...
Breaking Biology Technology:
(Date:5/9/2016)... , UAE, May 9, 2016 ... when it comes to expanding freedom for high net ... Even in today,s globally connected world, there is ... conferencing system could ever duplicate sealing your deal with ... obtaining second passports by taking advantage of citizenship via ...
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
Breaking Biology News(10 mins):